Clinical Trials Directory

Trials / Conditions / Endometrial Cancer Recurrent

Endometrial Cancer Recurrent

8 registered clinical trials studyying Endometrial Cancer Recurrent — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
NCT06781151
Sun Yat-sen University—
RecruitingPROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
NCT03621904
Radboud University Medical Center—
RecruitingCLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
NCT05410717
Second Affiliated Hospital of Guangzhou Medical UniversityPhase 1
TerminatedA Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
NCT05001282
Elucida OncologyPhase 1 / Phase 2
TerminatedCrizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
NCT04030429
National Cheng-Kung University HospitalPhase 2
TerminatedONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
NCT03485729
Jazz PharmaceuticalsPhase 2
CompletedA Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
NCT03015129
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedA Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
NCT02922764
Inspirna, Inc.Phase 1